Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com
Emergent BioSolutions to Webcast Presentation at the 32nd Annual J.P. Morgan Healthcare Conference
ROCKVILLE, Md.–(BUSINESS WIRE)–Dec. 2, 2013– Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2014 at 9:00 AM Pacific. During the presentation, a member of the company’s management team will provide a corporate overview, which may include a discussion of the company’s recent business developments as well as preliminary 2013 financial results and financial guidance for full year 2014. The webcast of this presentation will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
Source: Emergent BioSolutions Inc.